Cognition Therapeutics Inc (US: CGTX) — Healthcare · Share Price, Chart & Market Data
About: Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.28 (+1.59%)
CGTXCognition Therapeutics Inc
Loading watchlist status…
Trade CGTX now
Cognition Therapeutics Inc share price
CGTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:32 am GMT+0
CGTX price performance
9.402%
5D
75.318%
1M
-12.925%
YTD
207.323%
1Y
CGTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:32 am GMT+0
CGTX details
CGTX Market Signals